Shanghai Conant Optical Co., Ltd. (HKG:2276)
Hong Kong · Delayed Price · Currency is HKD 51.80
-0.35 (-0.67%)
At close: Dec 30, 2025
Shanghai Conant Optical Revenue
Shanghai Conant Optical had revenue of 1.08B CNY in the half year ending June 30, 2025, with 30.45% growth. This brings the company's revenue in the last twelve months to 2.17B, up 13.84% year-over-year. In the year 2024, Shanghai Conant Optical had annual revenue of 2.06B with 17.11% growth.
Revenue (ttm)
2.17B CNY
Revenue Growth
+13.84%
P/S Ratio
10.91
Revenue / Employee
796.40K CNY
Employees
2,723
Market Cap
25.92B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.06B | 301.13M | 17.11% |
| Dec 31, 2023 | 1.76B | 198.32M | 12.70% |
| Dec 31, 2022 | 1.56B | 205.24M | 15.13% |
| Dec 31, 2021 | 1.36B | 262.92M | 24.05% |
| Dec 31, 2020 | 1.09B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 38.69B |
| Alibaba Health Information Technology | 36.09B |
| Sino Biopharmaceutical | 33.49B |
| CSPC Pharmaceutical Group | 28.65B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |